Assignee
AURIGENE DISCOVERY TECH LTD
IN·32 granted patents·22 pending applications·221 citations·filing 2012–2022
Top patents by PatentIndex Score
54 records- 0198US11680051B2Crystalline forms of 3-substituted 1,2,4-oxadiazoleAURIGENE DISCOVERY TECH LTD·Filed 2021·Granted Jun 20, 2023·6 cites·31 claims
- 0298US11465976B21,2,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Oct 11, 2022·10 cites·30 claims
- 0397US11136300B2Crystalline forms of 3-substituted 1,2,4-oxadiazoleAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Oct 5, 2021·13 cites·25 claims
- 0497US10995100B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted May 4, 2021·6 cites·3 claims
- 0596US10781189B21,2,4-Oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Sep 22, 2020·15 cites·38 claims
- 0696US9732095B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2015·Granted Aug 15, 2017·23 cites·135 claims
- 0795US11691987B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Granted Jul 4, 2023·3 cites·22 claims
- 0895US9044442B2Peptidomimetic compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Granted Jun 2, 2015·29 cites·17 claims
- 0994US11865114B2Method for treating diseases using SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Jan 9, 2024·5 cites·46 claims
- 1093US10047104B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Aug 14, 2018·11 cites·135 claims
- 1193US9937155B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Apr 10, 2018·6 cites·40 claims
- 1292US11174232B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Nov 16, 2021·3 cites·14 claims
- 1391US11497734B2Dual inhibitors of TIM-3 and PD-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Nov 15, 2022·11 cites·29 claims
- 1491US10160753B2Indazole compounds as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2015·Granted Dec 25, 2018·14 cites·129 claims
- 1591US9630932B2Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Apr 25, 2017·13 cites·40 claims
- 1690US11497735B2Conjoint therapies for immunomodulationAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Nov 15, 2022·8 cites·31 claims
- 1790US10640517B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted May 5, 2020·6 cites·135 claims
- 1889US10080740B2Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Sep 25, 2018·6 cites·12 claims
- 1988US10689347B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Jun 23, 2020·4 cites·30 claims
- 2088US9062075B2Tetrahydropyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Jun 23, 2015·8 cites·19 claims
- 2187US11147801B2Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Oct 19, 2021·4 cites·12 claims
- 2281US11274123B21,2,4-oxadiazole compounds as inhibitors of CD47 signallingAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Mar 15, 2022·1 cites·17 claims
- 2381US9062002B2Substituted pyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2012·Granted Jun 23, 2015·8 cites·19 claims
- 2480US11419875B2Compounds and compositions for treating hematological disordersAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Aug 23, 2022·5 cites·51 claims
- 2578US2023110077A11,2,4-Oxadiazole and Thiadiazole Compounds as ImmunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 2676US11311517B2Combination of small molecule CD-47 inhibitors with other anti-cancer agentsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Apr 26, 2022·2 cites·11 claims
- 2776US2023062570A1Dual inhibitors of tim-3 and pd-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 2875US11186576B2Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Nov 30, 2021·1 cites·22 claims
- 2969US11229636B2Substituted tetrahydroquinolinone compounds as ROR gamma modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 25, 2022·0 cites·41 claims
- 3066US2019105304A1Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Application pending·0 cites
- 3164US2022281871A1Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 3260US2022339161A1Compounds and compositions for treating hematological disordersAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 3359US12371426B2Pyridazine derivatives as SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jul 29, 2025·0 cites·118 claims
- 3459US2021379024A1Method of modulating tigit and pd-1 signalling pathways using 1,2,4-oxadiazole compoundsAURIGENE DISCOVERY TECH LTD·Filed 2019·Application pending·0 cites
- 3558US2020061030A1Dual inhibitors of vista and pd-1 pathwaysAURIGENE DISCOVERY TECH LTD·Filed 2017·Application pending·0 cites
- 3658US2016194295A11,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives as ImmunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Application pending·0 cites
- 3758US2022324878A1Imidazolidin-2-one compounds as prmt5 modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 3856US2018200247A1Substituted Tetrahydroquinolinone Compounds as ROR Gamma ModulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 3954US2018369206A1Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Application pending·0 cites
- 4052US10894786B2Substituted pyrazole derivatives as selective CDK12/13 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 19, 2021·0 cites·25 claims
- 4150US2023027075A1Sulfonamide compounds targeting cd73 and adenosine receptorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 4249US2023212142A9Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 4346US2023119355A1Pharmaceutical compositions of a kinase inhibitorAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 4444US11365205B2Imidazolidin-2-one compounds as PRMT5 modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jun 21, 2022·0 cites·16 claims
- 4541US11542275B2Substituted imidazolidin-2-one derivatives as PRMT5 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 3, 2023·0 cites·19 claims
- 4639US2015183781A15-(1H-Pyrazol-4-yl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Application pending·0 cites
- 4738US9353107B23-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2013·Granted May 31, 2016·0 cites·17 claims
- 4837US2018044305A13-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 4937US2018044329A13-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulatorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
- 5037US2018208605A1Substituted Aza Compounds as IRAK-4 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →